Asthma: Targeted Biological Therapies
Alessandro Vatrella, Girolamo Pelaia, Rosario Maselli
Springer International Publishing AG, 2018
66,50 €On orderDelivery: 2-3 weeks
A range of therapies are considered, from the humanized monoclonal anti-IgE antibody omalizumab, widely approved as add-on treatment for inadequately controlled disease, through to emerging biologics for which evidence supportive of efficacy is accumulating, including anti-IL-5, anti-IL-4, and anti-IL-13 therapies.
- ISBN-13
- 9783319834177
- ISBN-10
- 3319834177
- Publisher
- Springer International Publishing AG
- Year
- 2018
- Publication date
- 2018-06-28
- Pages
- 99
- Dimensions
- 235x155x